These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 3351001)
1. View from the Nation's Capital. FDA moves forward (and backwards) on a number of simmering issues. Appler WD J Clin Psychopharmacol; 1988 Feb; 8(1):57-8. PubMed ID: 3351001 [No Abstract] [Full Text] [Related]
2. View from the nation's capital. Romansky MA J Clin Psychopharmacol; 1985 Feb; 5(1):51-2. PubMed ID: 2982923 [No Abstract] [Full Text] [Related]
3. View from the Nation's Capital. New drug application (NDA) and investigational new drug (IND) regulations. Romansky MA J Clin Psychopharmacol; 1983 Dec; 3(6):380-3. PubMed ID: 6680409 [No Abstract] [Full Text] [Related]
4. View from the Nation's Capital. Investigational new drug (IND) and new drug application (NDA). Romansky MA J Clin Psychopharmacol; 1983 Jun; 3(3):193-4. PubMed ID: 6680405 [No Abstract] [Full Text] [Related]
5. View from the Nation's Capital. Romansky MA J Clin Psychopharmacol; 1984 Jun; 4(3):161-2. PubMed ID: 6096408 [No Abstract] [Full Text] [Related]
6. View from the Nation's Capital. Romansky MA J Clin Psychopharmacol; 1984 Feb; 4(1):52-4. PubMed ID: 6096407 [No Abstract] [Full Text] [Related]
7. Desperation drugs. Frustrated AIDs patients are spurring the FDA to relax the rules of the game. Begley S; Hager M; Wilson L Newsweek; 1989 Aug; 114(6):48-9, 51. PubMed ID: 10293942 [No Abstract] [Full Text] [Related]
9. The FDA takes action against unapproved drugs. Meadows M FDA Consum; 2007; 41(1):34-5. PubMed ID: 17342837 [TBL] [Abstract][Full Text] [Related]
10. FDA bans 223 ingredients in nonprescription drug products. Clin Pharm; 1991 Feb; 10(2):88, 93. PubMed ID: 2009736 [No Abstract] [Full Text] [Related]
11. View from the Nation's Capital. FDA challenged successfully on its policies regarding good manufacturing practice inspections of medical drug and device manufacturers. Appler WD J Clin Psychopharmacol; 1987 Oct; 7(5):346-7. PubMed ID: 3680606 [No Abstract] [Full Text] [Related]
12. View from the Nation's Capitol. Romansky MA J Clin Psychopharmacol; 1982 Feb; 2(1):74-5. PubMed ID: 6926923 [No Abstract] [Full Text] [Related]
14. Second thoughts: do the FDA's responses to a fatal drug trial and the AIDS activist community's doubts about early access to drugs hint at a shift in basic FDA policy? Lovell MC Food Drug Law J; 1996; 51(2):273-94. PubMed ID: 11820202 [No Abstract] [Full Text] [Related]
15. A faster track for AIDS drugs? Kosterlitz J Natl J (Wash); 1989 Jul; 21(30):1931. PubMed ID: 10293944 [No Abstract] [Full Text] [Related]
16. View from the Nation's Capital. Romansky MA J Clin Psychopharmacol; 1983 Feb; 3(1):47-8. PubMed ID: 6680403 [No Abstract] [Full Text] [Related]
17. View from the Nation's Capital. Romansky MA J Clin Psychopharmacol; 1984 Oct; 4(5):288-9. PubMed ID: 6096409 [No Abstract] [Full Text] [Related]
18. New prescription for drug regulation. Pines WL FDA Consum; 1978 Jun; 12(5):7-10. PubMed ID: 10308117 [TBL] [Abstract][Full Text] [Related]
19. Panel recommends changes to expedite approval of cancer, AIDS drugs. Am J Hosp Pharm; 1990 Nov; 47(11):2410, 2413. PubMed ID: 2278248 [No Abstract] [Full Text] [Related]